Research workbench
GH115 alpha-1,2-glucuronidase in complex with xylopentaose
Analyse GH115 alpha-1,2-glucuronidase in complex with xylopentaose in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 7PUG
- Type
- protein
- Length
- 829 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Xylan alpha-1,2-glucuronidase
- EC
- 3.2.1.131
- Ligands
- XYP, CA, CL
- Pockets
- 7 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 36% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Xylan alpha-1,2-glucuronidase (EC 3.2.1.131) | protein | 829 | 36% helix, 19% strand | — |
Ligands and binding sites
- XYP · beta-D-xylopyranose · sugar · 5 copies · chains A
- CA · Calcium ion · metal · 3 copies · chains A
- CL · Chloride ion · ion · 13 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 479 | 0.69 | 0.80 | 50 | empty |
| 2 | 316 | 0.58 | 0.77 | 25 | empty |
| 3 | 66 | 0.54 | 0.87 | 16 | empty |
| 4 | 123 | 0.46 | 0.78 | 22 | XYP |
| 5 | 86 | 0.46 | 0.81 | 20 | empty |
Compared structures
- 7PUG · GH115 alpha-1,2-glucuronidase in complex with xylopentaose · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 7PUG · PDBe 7PUG
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.